Related Experiment Video
Updated: May 22, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
Published on: May 2, 2025
Is ARE/poly(U)-binding factor 1 (AUF1) a new player in cytokine-mediated beta cell apoptosis?
1Faculty of Medicine, Laboratory of Experimental Medicine, Université Libre de Bruxelles, Route de Lennik 808, Building G-E 5th floor, CP 618, 1070 Brussels, Belgium.
Abstract:
Type 1 diabetes is a chronic autoimmune disease involving the progressive loss of beta cell mass. Cytokines released by immune cells are early contributors to beta cell apoptosis. Thus, an understanding of the signal transduction mechanisms induced by cytokines in beta cells is necessary for the rational design of novel therapies to prevent or to cure this disease. Cytokine-mediated beta cell apoptosis is a complex phenomenon that includes activation of the transcription factors signal transducer and activator of transcription 1 and nuclear factor κB (NFκB), c-Jun N-terminal kinase, endoplasmic reticulum (ER) stress and the intrinsic mitochondrial apoptotic pathway. NFκB has both a pro-inflammatory and a pro-apoptotic role in beta cells. One of the mechanisms by which NFκB contributes to beta cell apoptosis is via activation of ER stress. The role for ER stress in beta cell apoptosis is not completely clarified but involves production of C/EBP homologous protein and activation of the intrinsic mitochondrial apoptotic pathway. In this issue of Diabetologia, Roggli et al (DOI 10.1007/s00125-011-2399-7) report on a new player in this elaborate response, the RNA-binding protein ARE/poly(U)-binding factor 1. This commentary discusses these findings and their relevance to the field.
Insights
Type 1 diabetes involves beta cell loss due to immune cell cytokines. A new study identifies the RNA-binding protein ARE/poly(U)-binding factor 1 as a key player in cytokine-induced beta cell death, offering therapeutic insights.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Type 1 diabetes is characterized by autoimmune destruction of pancreatic beta cells.
- Cytokines secreted by immune cells trigger beta cell apoptosis, contributing to disease progression.
- Understanding cytokine signaling pathways in beta cells is crucial for developing new therapies.
Purpose of the Study:
- To investigate the molecular mechanisms underlying cytokine-induced beta cell apoptosis.
- To identify novel regulatory factors involved in beta cell death pathways.
- To explore the role of the RNA-binding protein ARE/poly(U)-binding factor 1 in this process.
Main Methods:
- Analysis of signal transduction pathways activated by cytokines in beta cells.
- Investigation of the involvement of transcription factors like NFκB and JNK.
- Examination of endoplasmic reticulum (ER) stress and mitochondrial apoptotic pathways.
- Identification and characterization of the RNA-binding protein ARE/poly(U)-binding factor 1.
Main Results:
- Cytokine-mediated beta cell apoptosis involves activation of NFκB, JNK, ER stress, and mitochondrial pathways.
- NFκB contributes to beta cell apoptosis, partly through ER stress induction.
- The RNA-binding protein ARE/poly(U)-binding factor 1 emerges as a significant factor in these apoptotic responses.
- ER stress activation involves C/EBP homologous protein and the mitochondrial pathway.
Conclusions:
- ARE/poly(U)-binding factor 1 is a newly identified player in cytokine-induced beta cell apoptosis.
- These findings provide new targets for therapeutic interventions aimed at preserving beta cell mass in Type 1 diabetes.
- Further research into this RNA-binding protein could lead to novel strategies for Type 1 diabetes treatment.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
The JAK-STAT Signaling Pathway
Regulation of the Unfolded Protein Response
Apoptosis

